This item requires a subscription to Diabetes Care.
Cover
Full Text
Original Research - Emerging Treatments and Technologies:
  • Kristina I. Rother,
  • Lisa M. Spain,
  • Robert A. Wesley,
  • Benigno J. Digon III,
  • Alain Baron,
  • Kim Chen,
  • Patric Nelson,
  • H.-Michael Dosch,
  • Jerry P. Palmer,
  • Barbara Brooks-Worrell,
  • Michael Ring,
  • and David M. Harlan
Effects of Exenatide Alone and in Combination With Daclizumab on β-Cell Function in Long-Standing Type 1 Diabetes Diabetes Care December 2009 32:2251-2257; doi:10.2337/dc09-0773
To view this item, select one of the options below:

This Article

  1. doi: 10.2337/dc09-0773 Diabetes Care December 2009 vol. 32 no. 12 2251-2257
  1. AbstractFree
  2. » Full Text
  3. Full Text (PDF)
  4. All Versions of this Article:
    1. dc09-0773v1
    2. 32/12/2251 most recent

Current Issue

  1. February 2010, 33 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes Care